Qilian International Renames to 03 Life Sciences Inc.
Ticker: BGM · Form: 6-K · Filed: Mar 11, 2024 · CIK: 1779578
| Field | Detail |
|---|---|
| Company | Qilian International Holding Group LTD (BGM) |
| Form Type | 6-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: name-change, corporate-action, meeting
TL;DR
Qilian International is changing its name to 03 Life Sciences Inc. - EGM on March 28th to vote.
AI Summary
Qilian International Holding Group Ltd. announced an Extraordinary General Meeting to be held on March 28, 2024. The meeting will discuss and vote on a proposed change of the company's registered name to '03 Life Sciences Inc.' and a related amendment to its Articles of Association. This name change reflects a strategic shift in the company's business focus.
Why It Matters
The name change from Qilian International Holding Group Ltd. to 03 Life Sciences Inc. signals a potential strategic pivot, which could impact investor perception and the company's future business direction.
Risk Assessment
Risk Level: medium — The company is undergoing a significant name and potential strategic change, which introduces uncertainty about its future operations and financial performance.
Key Players & Entities
- Qilian International Holding Group Ltd (company) — Registrant
- 03 Life Sciences Inc. (company) — Proposed new company name
- March 28, 2024 (date) — Date of Extraordinary General Meeting
- March 2024 (date) — Reporting period for Form 6-K
FAQ
What is the primary purpose of the Extraordinary General Meeting?
The primary purpose is to vote on a special resolution to change the company's registered name from Qilian International Holding Group Ltd. to 03 Life Sciences Inc. and to amend the Articles of Association accordingly.
When is the Extraordinary General Meeting scheduled to take place?
The Extraordinary General Meeting is scheduled to be held on March 28, 2024.
What is the proposed new name for the company?
The proposed new name for the company is 03 Life Sciences Inc.
What documents are attached to this Form 6-K filing?
Attached to this Form 6-K filing are Exhibit 99.1 and Exhibit 99.2, which contain a Notice of Extraordinary General Meeting.
What is the company's current principal executive office address?
The company's principal executive office is located at Jiuquan Economic and Technological Development Zone, Jiuquan City, Gansu Province, 735000, People's Republic of China.
Filing Stats: 469 words · 2 min read · ~2 pages · Grade level 13.9 · Accepted 2024-03-11 06:02:50
Filing Documents
- tm247977d1_6k.htm (6-K) — 13KB
- tm247977d1_ex99-1.htm (EX-99.1) — 641KB
- tm247977d1_ex99-2.htm (EX-99.2) — 22KB
- tm247977d1_ex99-1img003.jpg (GRAPHIC) — 2KB
- 0001104659-24-032626.txt ( ) — 680KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: March 11, 2024 QILIAN INTERNATIONAL HOLDING GROUP LIMITED By: /s/ Zhanchang Xin Name: Zhanchang Xin Title: Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) Exhibits Exhibit No. Description 99.1 Notice of Extraordinary General Meeting of Shareholders and Proxy Statement 99.2 Proxy Card